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Abstract This pictorial review is based on our experience
of the follow-up of 120 patients at our multidisciplinary
center for hereditary hemorrhagic telangiectasia (HHT).
Rendu-Osler-Weber disease or HHT is a multiorgan auto-
somal dominant disorder with high penetrance,
characterized by epistaxis, mucocutaneous telangiectasis,
and visceral arteriovenous malformations (AVMs). The
research on gene mutations is fundamental and family
screening by clinical examination, chest X-ray, research of
pulmonary shunting, and abdominal color Doppler sonog-
raphy is absolutely necessary. The angioarchitecture of
pulmonary AVMs can be studied by unenhanced multide-
tector computed tomography; however, all other
explorations of liver, digestive bowels, or brain require
administration of contrast media. Magnetic resonance
angiography is helpful for central nervous system screening,
in particular for the spinal cord, but also for pulmonary,
hepatic, and pelvic AVMs. Knowledge of the multiorgan
involvement of HHT, mechanism of complications, and
radiologic ﬁndings is fundamental for the correct manage-
ment of these patients.
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Introduction
Hereditary hemorrhagic telangiectasia (HHT), or Rendu-
Osler-Weber disease, is an autosomal dominant multiorgan
pathology with a prevalence of 1 in 10,000 to 1 in 5000 [1]
and characterized by the presence of multiple small
telangiectases of the skin, mucous membranes, gastroin-
testinal tract, and other organs, with associated recurrent
episodes of bleeding from affected sites. Although every-
day symptoms in these patients are dominated by epistaxis
that may markedly alter their quality of life, more severe
manifestations of the disease are due to the consequences
of pulmonary arteriovenous malformations (PAVMs) and,
less often, to liver, brain, or gastrointestinal tract involve-
ment [1]. The diagnosis of HHT requires the presence of at
least three of the following Curacao criteria: recurrent
spontaneous epistaxis, mucocutaneous telangiectasis, an
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and visceral AVMs.
The mutations of the endoglin gene (ENG) on the 9q
chromosome and the aktivine gene (ALK1) on the 12q
chromosome are implicated in the inheritance of this dis-
ease [2]. Furthermore, the ENG mutations determine the
HHT1 disease subtype, which correlates with a more crit-
ical pulmonary involvement, and AKL1 mutations indicate
the HHT2 subtype, with a predominance of liver involve-
ment [2].
The purpose of this article is to provide a brief review of
the visceral involvement and the relevant ﬁndings on
diagnostic and therapeutic imaging.
Lung
PAVM is the most frequent lesion of the lung in patients
with HHT. It occurs in 20% to 50% and provokes different
clinical symptoms, such as dyspnea, cyanosis, massive
hemoptysis, and hemothorax [1]. The shunt induces various
paradoxical emboli such as cruoric, bacterial, and gaseous
[1]. Currently, it is known that for clinical relevance, the
diameter of the artery of the PAVM must be C3 mm.
However, one case with a feeding artery diameter\3m m
(Fig. 1) and responsible for ischemic stroke has been
reported [3].
The anatomic structure of the PAVM is classiﬁed
according to the two types [4] deﬁned as simple, with a
single artery feeding into an aneurysmal communication
with a single draining vein (Fig. 2, Movies 1 and 2), and
complex, with two or more arterial branches communi-
cating via an aneurysm with two or more draining veins
(Fig. 3). On chest X-ray, a PAVM classically appears as a
well-deﬁned nodule with a minimum of two branching
vessels (Fig. 4A). However, chest X-ray, although rather
speciﬁc, is not sensitive [5]. Diagnosis is performed on
unenhanced helical CT with a small slab of maximum
intensity projection reconstruction showing one or more
enlarged arteries, feeding a serpiginous mass or nodule,
and one or more draining veins (Fig. 4B and C) [5]. Con-
trast-enhanced magnetic resonance angiography (CE-
MRA) shows clearly all PAVMs (Fig. 4D) whose feeding
arteries are larger than 3 mm [6]. Because PAVMs have
predilections for affecting the lower lobes, exploration of
the pleural sac is fundamental (Fig. 5A). Pulmonary angi-
ography, which is an invasive procedure, less effective than
chest CT, is no longer used for diagnostic purposes and its
use is restricted to treatment. Transarterial PAVM vaso-
occlusion with coils (Fig. 5B and C) is currently the
treatment of choice [1]. Because of possible reperfusion
more than the development of small PAVMs due to
redistribution of the hemodynamic ﬂow after transcatheter
occlusion of large PAVMs, a CT or CE-MRA follow-up
(Fig. 6A and B) is recommended [6]. Reperfusion of
occluded PAVMs occurs in as many as 19% [7] of them
after initially successful treatment (Fig. 7A); the ﬂux
through the coils is better seen on CE-MRA (Fig. 7B) and
is conﬁrmed during the new vaso-occlusion procedure
(Fig. 7C). Reperfusion risk increases with increasing
PAVM feeding artery diameter, the use of a small number
of coils (one or two) [8] (Fig. 8) or oversized coils, and coil
placement proximally within the feeding artery. When
reperfusion appears, the patient remains at risk for com-
plications, so a new embolization must be performed [9].
When the cause is too proximal coil placement, the
reperfusion can be due to a hypertrophy of a bronchial or
systemic artery [10]; such a reperfusion does not cause
shunting but can be responsible for hemoptysis.
Brain
The mechanisms of central nervous system (CNS)
involvement in HHT are distal emboli, cerebrovascular
malformation (CVM), and metabolic disorders [2, 11].
PAVM shunting that avoids the ﬁltering effect of pul-
monary capillaries is the most frequent mechanism
inducing cerebral embolism and subsequent stroke (Fig. 9)
or brain abscess secondary to cruoric and septic emboli,
Fig. 1 A 20-year-old woman without a personal or family history
fulﬁlling the Curacao criteria was admitted for cerebral transient
ischemic attack; after complete clinical and paraclinical investigations
the only abnormality found was paradoxical emboli through a small
pulmonary arteriovenous malformation (PAVM). Maximal intensity
projectionMDCTshowingthefeedingartery(2),theaneurism,andthe
draining vein of a simple unique lower right lobe PAVM. The feeding
artery is smaller than 3 mm; nevertheless, it had a clinical impact
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ondary to chronic hypoxemia favors in situ formation of a
cruoric embolus [1]. Multiple ischemic strokes in different
arterial territories at different ages characterize the embolic
mechanism in HHT (Fig. 9). Brain abscess is the most
serious neurologic complication, occurring in 5% to 10%
of patients with PAVM. Typically in HHT these abscesses
are multiple and recurrent, affecting the superﬁcial layers
of the cerebral lobes (mostly the parietal lobe) and
developing often between the third and the ﬁfth decade of
life, when PAVMs increase in size and number. Transar-
terial PAVM vaso-occlusion is a key procedure to prevent
these cerebral complications in HHT.
Spinal and cerebral vascular malformations are mani-
festations of underlying vascular dysplasia [12]. These
lesions represent abnormal arteriovenous connections that
failed to differentiate properly into arteriolar, capillary, and
venular channels [13]. On magnetic resonance imaging
Fig. 2 A 57-year-old woman
with a personal and familial
(father, brother, and
grandfather) history of epistaxis
and multiples telangiectasia
presented dyspnea leading to
performance of a chest CT scan
which discovered a unique
pulmonary arteriovenous
malformation (PAVM) of the
left lower lobe. (A) Maximal
intensity projection MDCT on
the parasagittal plane shows a
feeding artery (arrow), the
aneurysm, and the draining vein
(arrowhead) of a simple unique
lower left lobe PAVM. (B)
Anterior view of volume-
rendering technique MDCT of
the same lower left lobe PAVM.
(C) Movie 1: A 360 view of the
lower left PAVM. (D) Left
lower lobe PAVM angiogram
showing clearly the serpiginous
architecture with one pulmonary
artery (black arrow) feeding the
PAVM and one draining vein
(white arrow) without
identiﬁcation of an aneurysmal
sac. (E) Movie 2: Dynamic
angiogram of this PAVM shows
the dynamic circulation of the
iodine contrast
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insinuating into the brain parenchyma (Fig. 11). Patients
with HHT often have multiple malformations of various
types, some of them with an atypical or indeterminate MRI
appearance [14]. Cerebral angiography may be required for
diagnosis of equivocal lesions and for planning of treat-
ment. The therapy for symptomatic CVMs is surgical
resection, stereotactic radiosurgery, embolization, or a
combination of these treatments [15].
Finally, the T1-weighted image hyperintensity of the
basal nuclei correlates with a metabolic disorder related to
hepatic portal vein shunt [16].
Liver
Hepatic involvement occurs in 30% to 73% of patients with
HHT; most of them are asymptomatic or have a slight
elevation of c-glutamyltransferase (GGT) but rare com-
plications occur, especially in female patients [11, 17].
Three different and often concurrent types of intrahe-
patic shunts (hepatic artery to hepatic veins, hepatic artery
to portal vein, and portal vein to hepatic veins) are
responsible for the parenchymal, vascular, and bile duct
signs [11]. Hepatic abnormalities are diagnosed by Doppler
ultrasound, MDCT, MRI, and MRA. Hepatic ultrasound
associated with Doppler is a good tool with an experienced
investigator [18]; otherwise ﬁndings can be considered as
normal in the early stage because telangiectases are difﬁ-
cult to diagnose. The diameter of the common hepatic
artery ([7 mm; Fig. 12A) and intrahepatic hypervascular-
ization are suitable sonographic diagnostic parameters of
HHT with a high sensitivity and speciﬁcity [18]. Rarely,
Doppler ultrasound can reveal pulsatile portal ﬂow (arte-
rioportal shunt; Fig. 12B) or pulsatile hepatic vein ﬂow
(arteriovenous shunt; Fig. 12C).
Hepatic vascular lesions on MDCT range from tiny tel-
angiectases (Fig. 12D) to transient perfusion abnormalities
andlargeconﬂuentfocalvascularmasses[19].Theselesions
are often associated with arteriovenous, arterioportal, or
portovenous shunts and hepatic artery enlargement
(Fig. 12E–G). Telengiectases are hypervascular rounded
nodules (varying from a few millimeters to 1 cm in size)
localized in a subcapsular position in the arterial and late
arterial phases, often becoming isointense with the hepatic
parenchyma in the hepatic parenchymal phase. Arteriogra-
phy, too aggressive for a screening and diagnosis tool, could
be the best method to characterize telangiectases.
The natural evolution of hepatic teangiectasia in MRO
patients is toward intrahepatic vascular shunts [20]. If
simple telangiectasis can rarely provoke a painful liver
with a slight elevation of GGT, arteriovenous shunts are
more communicative. An arterioportal shunt may rarely
induce portal hypertension, ascites, encephalopathy, and
hematemesis. An arteriovenous shunt can, on rare occa-
sions, be responsible for high-output heart failure and
necrotizing cholangitis by arterial ﬂow steal (the arterial
supply of the biliary duct is exclusively dependent on the
hepatic artery) [20]. Livers in patients with HHT may show
either diffuse or partial hepatocellular regenerative activity,
leading to regenerative focal nodular hyperplasia (FNH;
Fig. 13A–D). The prevalence of FNH in patients with HHT
is 100-fold greater than in the general population and can
lead to dangerous hepatic biopsies. The combination of
ﬁbrosis (around abnormal vessels), nodular regenerative
hyperplasia, and portal hypertension may lead to a misdi-
agnosis of cirrhosis [11]. Occasionally, patients with HHT
present with true cirrhosis (secondary to extensive necro-
tizing cholangitis), hepatocarcinoma, or hemobilia
(secondary to a MAV rupture in the biliary system). An-
giomas can also coexist with telangiectases and hepatic
MAV. Rarely, pancreatic telangiectasis can be associated
with liver lesions (Fig. 14).
Fig. 3 A 23-year-old woman with a personal and familial history of
HHT, in particular, a cerebral arteriovenous malformation in her
grandmother, was sent for occlusion of multiple PAVMs including a
complex malformation with two different segmental (arrowheads)
arteries (lingular and left ventral inferior arteries) feeding a large
reticulated ﬁstula drained by two segmental veins (arrow)
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has been performed but fatal outcomes due to necrotizing
cholangitis suggest caution in its use. Orthotopic liver
transplantation may represent the only deﬁnitive curative
option for hepatic vascular malformations in HHT, even
though at this time relapse has been observed in 2 of 28
patients undergoing transplantation [17].
Gastrointestinal Tract
Recurrent upper or lower gastrointestinal bleeding
occurs in approximately 20% of patients with HHT and
is responsible for anemia. The risk of fatal bleeding is
mostly due to intestinal mucosal telangiectasis pre-
dominating in the gastroduodenal region, and less,
frequently to intestinal AV shunt or angiodysplasia.
Classical imaging techniques are limited. Only large AV
malformations can be diagnosed on CT scan. The
technique of capsule endoscopy is emerging to study the
small bowel. Endoscopy is the gold standard for diag-
nosis and therapy of gastroduodenal and colonic
telangiectases [21].
Summary
In summary, knowledge of genetic ﬁndings and of
phenotypes leads to optimal management of the patient
and family. In these patients, diagnosis and adequate
therapeutic choice, with a multidisciplinary approach,
can prevent serious complications and avoid the
need for hepatic biopsies in the case of hepatic
involvement.
Fig. 4 A 45-year-old man with
a personal and familial (father,
sister, and daughter) history of
epistaxis and multiple
telangiectasia presented
pulmonary nodules on a chest
X-ray. Unenhanced MDCT
shows multiple PAVMs; right-
to-left shunting was calculated
as 17%. (A) Chest X-ray shows
two well-deﬁned nodules
(arrows) with branching vessels
(arrowheads). The third one is
doubtful (large white arrow).
(B) MDCT coronal 30-mm-
thick slab maximal intensity
projection conﬁrms the vascular
structure of the nodules with
branching vessels identiﬁed on
the chest X-ray. Furthermore, it
conﬁrms the lower left PAVM
(arrow) and shows a small right
lower lobe PAVM not identiﬁed
by chest X-ray (arrowhead). (C)
MDCT axial 20-mm-thick slab
maximal intensity projection
shows clearly three PAVMs on
the extreme right lower lobe
(stars). These PAVMs are not
visible on the chest X-ray. (D)
Coronal CE-MRA shows the
anatomy of the right upper lobe
PAVM seen on the chest X-ray,
with the feeding pulmonary
artery (white arrowheads), the
aneurysmal sac (arrow), and the
draining vein (black
arrowheads)
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Fig. 6 A 24-year-old
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(arrow) reveals several smaller
but clinically signiﬁcant
(pulmonary artery diameters,
[3 mm) ﬁstulae in the anterior
and subpleural space
(arrowheads). Both series were
performed using the same rate
(20 ml/s) and contrast volume
(40 ml)
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123Fig. 7 Follow up of the 45-year-old patient described in the legend to
Fig. 3. Coronal maximal intensity projection MDCT (A) and coronal
contrast-enhanced MRA (B) show the reperfusion of a treated PAVM.
The absence of coil artifact in CE-MRA gives a direct sign of
reperfusion by visualizing the reperfused artery (arrowheads). The
MDCT signs are indirect: persistence of the aneurysmal sac and of a
large draining vein. (C) Standard angiography conﬁrms the reperfu-
sion. The elongation of the uncompacted coil and the proximal
placement of the coil into the feeding artery were probably risk
factors for reperfusion
b
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123Fig. 9 A 36-year-old woman presenting with multiple acute cerebral
infarctions. The intracerebral and cervical vessel checkup was normal
except for the left vertebral artery occlusion. The cardiac evaluation
and chest CT scan show a right-to-left shunt by a large PAVM of the
internal segment of the right middle lobe. The genetic study was
positive for ALK1, but it is not formally recognized as a pathogen by
geneticists. (A) Serial images of diffusion weighted images (diffusion
b value = 1000 s/mm
2) shows multiple cerebral infarction involving
the right middle cerebral artery (white arrows), the right (white
arrowheads) and left (black arrows) posterior cerebral arteries, and the
right superior cerebella artery (black arrowheads) territories. (B)
CE-MRA of the neck vessels shows a left vertebral artery occlusion
(arrow), potentially to cruoric emboli
Fig. 8 A 77-year-old woman diagnosed with HHT with pulmonary
involvement and AKL1 genotype, with a history of PAVM emboliza-
tion and reperfusion, neurological complications, and important
epistaxis was hospitalized for repeat transcatheter occlusion of a
reperfused PAVM. (A) Superselective angiogram of the feeding artery
(white arrow) shows the single coil (white arrowhead), the aneurysmal
sac (asterisk), and the large draining vein (black arrow). (B) Superse-
lective angiogram control of the PAVM shows complete occlusion of
thefeedingartery(whitearrow)andtheaneurysm.Although,toprevent
reperfusion, the ﬁrst single coil was placed distally, right next to the
aneurysmal sac, reperfusion occurred. The use of a single coil is a risk
factor for reperfusion
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123Fig. 10 A 25-year-old woman presenting with headache and fever.
Enhanced CT scan shows a ring contrast enhancement mass of the
right basal ganglia in association with a brain abscess. The etiological
research revealed multiple PAVMs and mucocutaneous telangiectasis
consistent with HHT
Fig. 11 A 55-year-old woman with HHT presenting important
epistaxis inducing anemia, multiple telangiectasis, and liver and
pancreatic involvement without pulmonary abnormalities. She had
brain MR angiography for systematic evaluation, which shows a
small cebrovascular malformation (arrow): follow-up and no endo-
vascular treatment were decided
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123Fig. 12 Hepatic abnormalities
in several patients with HHT.
(A) Hepatic artery (A)
enlargement at 9 mm on
ultrasound (US). (B) Doppler
US of the right portal branch
shows pulsatile portal ﬂow
consistent with an hepatic
artery-to-portal vein shunt
(arterioportal shunt). (C)
Doppler US of the left hepatic
vein shows pulsatile ﬂow into
the left hepatic vein consistent
with an hepatic artery-to-hepatic
vein shunt (arterioveinous
shunt). (D) A 2-mm-thick
coronal reformatting MDCT
during arterial phase shows
hepatic telangiectasis (arrows).
(E) Axial, (F) sagittal, and (G)
coronal maximal intensity
projection MDCT reformatting
with a 15-mm slice shows major
hepatic artery hypertrophy with
arterial calciﬁcations (black
arrow) and celiac trunk
hypertrophy in a patient with
giant left basal PAVM
(asterisk). Note the left inferior
phrenic artery (white arrow)
enlargement (in comparison
with the right inferior phrenic
artery; white arrowheads) to
supply the ﬂow steal of the left
lower lobe pulmonary artery by
the giant PAVM, inducing
relative lower lobe ischemia
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by liver MRI: liver pseudotumor and vascular malformations. (A)
Axial TSE T2 short TI inversion recovery (TSE-STIR) image shows a
hyperintense mass involving segment VII (arrow) without any
abnormalities in segment VIII. (B) Axial T1-weighted fast low-angle
shot (FLASH) image shows the hyper signal ring of the segment VII
lesion and isointensity relative to the normal hepatic tissue signal
mass of segment VIII. (C) Axial fat-suppressed T1-weighted FLASH
image shows a homogeneous bright lesion with hypointense central
scar (black arrow) of the segment VIII lesion and the highly intense
ring of the segment VII lesion. (D) Axial delayed contrast-enhanced
T1-weighted FLASH image shows that the segment VII lesion has
homogeneous enhancement corresponding to vascular malformation,
and the segment VIII lesion is isointense relative to normal hepatic
tissue with enhancement of the central scar (black arrow) corre-
sponding to focal nodular hyperplasia. (E) Coronal arterial-phase
contrast-enhanced MR angiography shows hepatic artery enlargement
(black arrow) and hepatic artery-to-hepatic vein shunting with hepatic
vascular malformations. The rapid enhancement of the hepatic vein
(right arrow) before portal vein and renal vein enhancement signal the
hepatic artery-to-hepatic vein shunting within the hepatic vascular
malformation. (F) Coronal portal-phase contrast-enhanced MRA
shows that the portal vein (white arrow) is permeable and has the
same dimension as the enlarged hepatic artery (black arrow). (G)
Movie 3 shows the maximal intensity projection of arterial-phase
contrast-enhanced MR angiography of the upper abdominal area
756 M.-F. Carette et al.: Imaging of Hereditary Hemorrhagic Telangiectasia
123Fig. 14 A 55-year-old woman with a history of recurrent epistaxis,
intestinal bleeding, and liver involvement of HHT. Abdominal
contrast-enhanced MDCT shows hepatic and pancreatic abnormali-
ties. A 1-mm-thick axial image in the arterial phase shows clearly the
pancreatic telangiectasis (arrow), hepatic left lobe enhancement
heterogenicity, and hepatic artery enlargement
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